Industry: Medical Devices & Consumables
Published Date: 2026-01-04
Pages: 111 Pages
Report ld: 5529751
Request Sample
Customized Report
Prostate Biopsy Devices Market Size(US$)

CAGR 2026-2032
4.9%
Market Size,2032
USD 867
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Prostate Biopsy Devices market was valued at US$ 623 million in 2025 and is anticipated to reach US$ 867 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Prostate Biopsy Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Prostate biopsy is a procedure in which small hollow needle-core samples are removed from a man"s prostate gland to be examined microscopically for the presence of cancer.
Prostate biopsy samples can be collected in different ways. Your prostate biopsy may involve:
1. Passing the needle through the wall of the rectum (transrectal biopsy). This is the most common way of performing a prostate biopsy.
2. Inserting the needle through the area of skin between the anus and scrotum (transperineal biopsy). A small cut is made in the area of skin (perineum) between the anus and the scrotum. The biopsy needle is inserted through the cut and into the prostate to draw out a sample of tissue. An MRI or CT scan is generally used to guide this procedure.
The major players in global Prostate Biopsy Devices market include BD, Argon Medical Devices, etc. The top 2 players occupy about 60% shares of the whole market. North America and Europe are main markets, they occupy about 70% of the global market. Disposable Devices is the main type, with a share over 80%. Hospitals is the main application, which holds a share over 50%.
This report delivers a comprehensive overview of the global Prostate Biopsy Devices market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Prostate Biopsy Devices. The Prostate Biopsy Devices market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Prostate Biopsy Devices market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Prostate Biopsy Devices manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Prostate Biopsy Devices manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Prostate Biopsy Devices sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Prostate Biopsy Devices Market Overview
1.1 Product Definition
1.2 Prostate Biopsy Devices by Type
1.2.1 Global Prostate Biopsy Devices Market Value by Type: 2025 vs 2032
1.2.2 Reusable Devices
1.2.3 Disposable Devices
1.3 Prostate Biopsy Devices by Application
1.3.1 Global Prostate Biopsy Devices Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center (ASCs)
1.3.4 Diagnostic Centers
1.4 Global Prostate Biopsy Devices Market Size Estimates and Forecasts
1.4.1 Global Prostate Biopsy Devices Revenue 2021–2032
1.4.2 Global Prostate Biopsy Devices Sales 2021–2032
1.4.3 Global Prostate Biopsy Devices Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Prostate Biopsy Devices Market Competition by Manufacturers
2.1 Global Prostate Biopsy Devices Sales Market Share by Manufacturers (2021–2026)
2.2 Global Prostate Biopsy Devices Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Prostate Biopsy Devices Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Prostate Biopsy Devices, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Prostate Biopsy Devices, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Prostate Biopsy Devices, Product Types and Applications
2.7 Global Key Manufacturers of Prostate Biopsy Devices, Date of Entry into the Industry
2.8 Global Prostate Biopsy Devices Market Competitive Situation and Trends
2.8.1 Global Prostate Biopsy Devices Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Prostate Biopsy Devices Players Market Share by Revenue
2.8.3 Global Prostate Biopsy Devices Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prostate Biopsy Devices Market Scenario by Region
3.1 Global Prostate Biopsy Devices Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Prostate Biopsy Devices Sales by Region: 2021–2032
3.2.1 Global Prostate Biopsy Devices Sales by Region: 2021–2026
3.2.2 Global Prostate Biopsy Devices Sales by Region: 2027–2032
3.3 Global Prostate Biopsy Devices Revenue by Region: 2021–2032
3.3.1 Global Prostate Biopsy Devices Revenue by Region: 2021–2026
3.3.2 Global Prostate Biopsy Devices Revenue by Region: 2027–2032
3.4 North America Prostate Biopsy Devices Market Facts & Figures by Country
3.4.1 North America Prostate Biopsy Devices Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Prostate Biopsy Devices Sales by Country (2021–2032)
3.4.3 North America Prostate Biopsy Devices Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prostate Biopsy Devices Market Facts & Figures by Country
3.5.1 Europe Prostate Biopsy Devices Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Prostate Biopsy Devices Sales by Country (2021–2032)
3.5.3 Europe Prostate Biopsy Devices Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prostate Biopsy Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Prostate Biopsy Devices Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Prostate Biopsy Devices Sales by Region (2021–2032)
3.6.3 Asia Pacific Prostate Biopsy Devices Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Prostate Biopsy Devices Market Facts & Figures by Country
3.7.1 Latin America Prostate Biopsy Devices Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Prostate Biopsy Devices Sales by Country (2021–2032)
3.7.3 Latin America Prostate Biopsy Devices Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prostate Biopsy Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Prostate Biopsy Devices Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Prostate Biopsy Devices Sales by Country (2021–2032)
3.8.3 Middle East and Africa Prostate Biopsy Devices Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prostate Biopsy Devices Sales by Type (2021–2032)
4.1.1 Global Prostate Biopsy Devices Sales by Type (2021–2026)
4.1.2 Global Prostate Biopsy Devices Sales by Type (2027–2032)
4.1.3 Global Prostate Biopsy Devices Sales Market Share by Type (2021–2032)
4.2 Global Prostate Biopsy Devices Revenue by Type (2021–2032)
4.2.1 Global Prostate Biopsy Devices Revenue by Type (2021–2026)
4.2.2 Global Prostate Biopsy Devices Revenue by Type (2027–2032)
4.2.3 Global Prostate Biopsy Devices Revenue Market Share by Type (2021–2032)
4.3 Global Prostate Biopsy Devices Price by Type (2021–2032)
5 Segment by Application
5.1 Global Prostate Biopsy Devices Sales by Application (2021–2032)
5.1.1 Global Prostate Biopsy Devices Sales by Application (2021–2026)
5.1.2 Global Prostate Biopsy Devices Sales by Application (2027–2032)
5.1.3 Global Prostate Biopsy Devices Sales Market Share by Application (2021–2032)
5.2 Global Prostate Biopsy Devices Revenue by Application (2021–2032)
5.2.1 Global Prostate Biopsy Devices Revenue by Application (2021–2026)
5.2.2 Global Prostate Biopsy Devices Revenue by Application (2027–2032)
5.2.3 Global Prostate Biopsy Devices Revenue Market Share by Application (2021–2032)
5.3 Global Prostate Biopsy Devices Price by Application (2021–2032)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Company Information
6.1.2 BD Description and Business Overview
6.1.3 BD Prostate Biopsy Devices Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 BD Prostate Biopsy Devices Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Argon Medical Devices
6.2.1 Argon Medical Devices Company Information
6.2.2 Argon Medical Devices Description and Business Overview
6.2.3 Argon Medical Devices Prostate Biopsy Devices Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Argon Medical Devices Prostate Biopsy Devices Product Portfolio
6.2.5 Argon Medical Devices Recent Developments/Updates
6.3 Invivo
6.3.1 Invivo Company Information
6.3.2 Invivo Description and Business Overview
6.3.3 Invivo Prostate Biopsy Devices Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Invivo Prostate Biopsy Devices Product Portfolio
6.3.5 Invivo Recent Developments/Updates
6.4 Cook Medical
6.4.1 Cook Medical Company Information
6.4.2 Cook Medical Description and Business Overview
6.4.3 Cook Medical Prostate Biopsy Devices Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Cook Medical Prostate Biopsy Devices Product Portfolio
6.4.5 Cook Medical Recent Developments/Updates
6.5 TSK
6.5.1 TSK Company Information
6.5.2 TSK Description and Business Overview
6.5.3 TSK Prostate Biopsy Devices Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 TSK Prostate Biopsy Devices Product Portfolio
6.5.5 TSK Recent Developments/Updates
6.6 UROMED
6.6.1 UROMED Company Information
6.6.2 UROMED Description and Business Overview
6.6.3 UROMED Prostate Biopsy Devices Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 UROMED Prostate Biopsy Devices Product Portfolio
6.6.5 UROMED Recent Developments/Updates
6.7 Biomedical
6.7.1 Biomedical Company Information
6.7.2 Biomedical Description and Business Overview
6.7.3 Biomedical Prostate Biopsy Devices Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Biomedical Prostate Biopsy Devices Product Portfolio
6.7.5 Biomedical Recent Developments/Updates
6.8 Amecath
6.8.1 Amecath Company Information
6.8.2 Amecath Description and Business Overview
6.8.3 Amecath Prostate Biopsy Devices Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Amecath Prostate Biopsy Devices Product Portfolio
6.8.5 Amecath Recent Developments/Updates
6.9 Sterylab
6.9.1 Sterylab Company Information
6.9.2 Sterylab Description and Business Overview
6.9.3 Sterylab Prostate Biopsy Devices Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Sterylab Prostate Biopsy Devices Product Portfolio
6.9.5 Sterylab Recent Developments/Updates
6.10 Geotekmedical
6.10.1 Geotekmedical Company Information
6.10.2 Geotekmedical Description and Business Overview
6.10.3 Geotekmedical Prostate Biopsy Devices Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Geotekmedical Prostate Biopsy Devices Product Portfolio
6.10.5 Geotekmedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prostate Biopsy Devices Industry Chain Analysis
7.2 Prostate Biopsy Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prostate Biopsy Devices Production Mode & Process Analysis
7.4 Prostate Biopsy Devices Sales and Marketing
7.4.1 Prostate Biopsy Devices Sales Channels
7.4.2 Prostate Biopsy Devices Distributors
7.5 Prostate Biopsy Devices Customer Analysis
8 Prostate Biopsy Devices Market Dynamics
8.1 Prostate Biopsy Devices Industry Trends
8.2 Prostate Biopsy Devices Market Drivers
8.3 Prostate Biopsy Devices Market Challenges
8.4 Prostate Biopsy Devices Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Prostate Biopsy Devices market size was US$ 623 million in 2025 and is forecast to reach a readjusted size of US$ 867 million by 2032 with a CAGR of 4.9% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 79
USD 4250.00
(Single User License)
The global market for Prostate Biopsy Devices was estimated to be worth US$ 623 million in 2025 and is projected to reach US$ 867 million, growing at a CAGR of 4.9% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 110
USD 3950.00
(Single User License)
The global Prostate Biopsy Devices market is projected to grow from US$ 597 million in 2024 to US$ 830 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 131
USD 4900.00
(Single User License)
In 2024, the global market size of Prostate Biopsy Devices was estimated to be worth US$ 597 million and is forecast to reach approximately US$ 830 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 140
USD 5900.00
(Single User License)
The global Prostate Biopsy Devices market size was US$ 597 million in 2024 and is forecast to a readjusted size of US$ 830 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 78
USD 4250.00
(Single User License)
The global market for Prostate Biopsy Devices was estimated to be worth US$ 597 million in 2024 and is forecast to a readjusted size of US$ 830 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 91
USD 3950.00
(Single User License)
The global market for Prostate Biopsy Devices was valued at US$ 597 million in the year 2024 and is projected to reach a revised size of US$ 830 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Published Date: 2025-01-16
Pages: 80
USD 2900.00
(Single User License)
Prostate biopsy is a procedure in which small hollow needle-core samples are removed from a man's prostate gland to be examined microscopically for the presence of cancer.
Published Date: 2024-04-17
Pages: 167
USD 5600.00
(Single User License)
Prostate biopsy is a procedure in which small hollow needle-core samples are removed from a man's prostate gland to be examined microscopically for the presence of cancer.
Published Date: 2024-04-16
Pages: 148
USD 5900.00
(Single User License)
Prostate biopsy is a procedure in which small hollow needle-core samples are removed from a man's prostate gland to be examined microscopically for the presence of cancer.
Published Date: 2024-04-07
Pages: 109
USD 4900.00
(Single User License)
The global Prostate Biopsy Devices market size was US$ 623 million in 2025 and is forecast to reach a readjusted size of US$ 867 million by 2032 with a CAGR of 4.9% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 79
The global market for Prostate Biopsy Devices was estimated to be worth US$ 623 million in 2025 and is projected to reach US$ 867 million, growing at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-01-04
Pages: 110
The global Prostate Biopsy Devices market is projected to grow from US$ 597 million in 2024 to US$ 830 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 131
In 2024, the global market size of Prostate Biopsy Devices was estimated to be worth US$ 597 million and is forecast to reach approximately US$ 830 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 140
The global Prostate Biopsy Devices market size was US$ 597 million in 2024 and is forecast to a readjusted size of US$ 830 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 78
The global market for Prostate Biopsy Devices was estimated to be worth US$ 597 million in 2024 and is forecast to a readjusted size of US$ 830 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 91
The global market for Prostate Biopsy Devices was valued at US$ 597 million in the year 2024 and is projected to reach a revised size of US$ 830 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Published: 2025-01-16
Pages: 80
Prostate biopsy is a procedure in which small hollow needle-core samples are removed from a man's prostate gland to be examined microscopically for the presence of cancer.
Published: 2024-04-17
Pages: 167
Prostate biopsy is a procedure in which small hollow needle-core samples are removed from a man's prostate gland to be examined microscopically for the presence of cancer.
Published: 2024-04-16
Pages: 148
Prostate biopsy is a procedure in which small hollow needle-core samples are removed from a man's prostate gland to be examined microscopically for the presence of cancer.
Published: 2024-04-07
Pages: 109
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now